In Brief
Glucocorticoids are important antiinflammatory therapeutics. Jubb at al. find that treating primary macrophages with glucocorticoid induces rapid and persistent chromatin reorganization at genes that respond in both mice and humans. Higher-order chromatin structure at these core loci may be involved in the glucocorticoid response and be relevant to resistance.
INTRODUCTION
Glucocorticoids (GCs) are clinically important metabolic hormones with powerful anti-inflammatory effects. They are among the most widely prescribed therapeutic agents, but cardio-metabolic side effects and resistance limit their therapeutic use. Furthermore, GC resistance emerges in many patients with chronic inflammatory disease, and the basis of the lack of efficacy in acute inflammation associated with sepsis is not well understood (Dendoncker and Libert 2017; Rodriguez et al., 2016) . Dysregulation of endogenous GCs during severe illness has been linked to worse outcomes (Annane et al., 2000; Boonen et al., 2013) .
GCs act by binding to the glucocorticoid receptor (GR) (Nr3c1), which is a ligand-activated transcription factor (TF). Macrophages express GR at high levels (Forrest et al., 2014; Lattin et al., 2008) and are major targets of the anti-inflammatory and therapeutic impacts of GC treatment (Jubb et al., 2016; Oh et al., 2017) . Although there is evidence for direct trans-repression of pro-inflammatory genes by GCs (Uhlenhaut et al., 2013) , the major mechanism of action appears to involve induction of feedback regulators, such as Dusp1, IkBa, Tnfaip3, and Tsc22d3 (Jubb et al., 2016; Oh et al., 2017; Reddy et al., 2009; Vandevyver et al., 2012) . As an inducer of gene expression, GR binds in a ligand-dependent manner to DNA at sites (enhancers) that may lie many tens of kilobases from the target gene (Lim et al., 2015; Jubb et al., 2016; Reddy et al., 2009; So et al., 2007; Stavreva et al., 2015; Uhlenhaut et al., 2013) . GR binding is largely constrained to sites accessible to nuclease digestion and is associated with the nearby binding sites for pioneer TFs (Belikov et al., 2009; Biddie et al., 2011; Grøntved et al., 2013; Jubb et al., 2016; Starick et al., 2015) . As a consequence, GR target genes can vary between tissue and cell types. In the case of macrophages, GR binding is strongly associated with binding sites for the macrophage lineage TF PU.1 (Jubb et al., 2016; Oh et al., 2017) , and further binding sites become available upon inflammatory activation, associated with AP1 and RelA binding (Oh et al., 2017) . The transcriptional response of macrophages to GCs varies markedly between humans and mice, associated with the gain and loss of GR binding sequence motifs (Jubb et al., 2016) . GR binding can also initiate the formation of a more nuclease-sensitive local chromatin structure Burd and Archer 2013; Hakim et al., 2011; Stavreva et al., 2015) . This may be transient, disappearing rapidly upon hormone withdrawal, or may persist well beyond the period of hormone treatment (Stavreva et al., 2015) .
As well as altering local nucleosome structure, some nuclear hormone receptors, such as the estrogen receptor, can modulate chromatin structure at a scale sufficiently large to be detectable by light microscopy (Nye et al., 2002; Rafique et al., 2015) . There have been few reports on GR actions at this level of chromosome structure. At a repetitive array of the mouse mammary tumor virus (MMTV) promoter, GR binding results in transcription-dependent visible chromatin decompaction over the course of a few hours (M€ uller et al., 2001) . Conversely, 4C chromatin conformation capture assays of the GR-responsive Lcn2 locus in a mammary adenocarcinoma cell line indicated that GR binding produced only a modest effect on long-range chromatin contacts captured with this approach (Hakim et al., 2011) .
We previously identified inducible sites of GR binding at likely enhancers of genes induced by GC in primary mouse and human macrophages (Jubb et al., 2016) . Here, using fluorescence in situ hybridization (FISH), we demonstrate rapid, persistent, and visible chromatin decompaction-increases in inter-probe distances-at multiple GC-responsive loci in mouse bonemarrow-derived macrophages (mBMDMs) following dexamethasone treatment. We compare and contrast the behavior of loci in which the GC response is conserved in mice and humans with loci whose response to GC is specific to mouse macrophages. Our data provide insight into how GCs affect large-scale chromatin structure in macrophages and indicate that there may be a long-term ''memory'' of GR binding on chromatin.
RESULTS

GC Induces Rapid GR Binding at Enhancers at the Fkbp5 Locus
We have previously generated genome-wide expression and GR binding data in primary mouse and human macrophages responding to 100 nM dexamethasone (Dex), a GR agonist (Jubb et al., 2016) . These GR binding sites bear the hallmarks of enhancers, being enriched in PU.1 binding sites, and active enhancer histone marks in unstimulated mBMDMs (Ostuni et al., 2013) (Figure S1A ). Many GC-inducible genes were regulated only in one species or the other, associated with gain and loss of GR motifs from the respective genome. Even for genes that were induced in both species, the precise site of GR binding was not always conserved. In this study, we first focused on Fkbp5, a GR co-chaperone and inducible feedback regulator of the GC response. Elevated Fkbp5 levels reduce the affinity of GR for the agonist and are associated with resistance (Denny et al., 2000; Jä ä skelä inen et al., 2011; Vandevyver et al., 2012; Zannas et al., 2016) .
Fkbp5 is strongly induced by Dex in both mouse and human macrophages. The time course of Fkbp5 mRNA induction in BMDMs is shown in Figure 1A . In human A549 lung carcinoma cells, GR binding sites have been described 34 kb 5 0 and 87 kb 3 0 of the FKBP5 transcription start site (TSS) (Reddy et al., 2009) . In human macrophages, we also identified two major GR binding sites in similar locations (Jubb et al., 2016) . In mBMDMs, chromatin immunoprecipitation sequencing (ChIPseq) revealed strong GR binding at a site 28 kb upstream of Fkbp5 (À28 kb) and at an intragenic site (+65 kb) after 1 hr of Figure 1 . GC Causes Rapid and Prolonged Chromatin Decompaction at the Fkbp5 Locus (A) Expression data in response to 100 nM dexamethasone (Dex) for Fkbp5 at the time points indicated (Jubb et al., 2016 Figure S1B ). (D) 3D DNA FISH images of nuclei from mBMDM treated with 100 nM Dex or vehicle control for 5 min using the probes indicated in (A). Scale bar represents 1 mm. (E) Boxplots of inter-probe distances (mm) measured across the Fkbp5 locus at the indicated times following treatment with vehicle or 100 nM Dex; n = 80 for each condition. Horizontal line, median; whiskers, 1.53 interquartile range; *p < 0.05, **p < 0.005, ***p < 0.0005, Wilcoxon rank sum. (F) As for (E) but after culturing for prolonged periods after Dex washout. (G) GR binding measured by ChIP-qPCR for the Fkbp5 downstream enhancer (+65 kb) and Actb promoter following stimulation with 100 nM Dex at 1 and 24 hr with (1h+23w) and without (24h) washout of the ligand. Error bars are 23 SEM for three technical replicates (a further biological replicate is shown in Figure S1C ).
Dex exposure ( Figure 1B ). As seen for most GC-responsive genes in macrophages from both species (Jubb et al., 2016) , no GR binding was detected at the Fkbp5 promoter. Both GR enhancer locations in the two species correspond to putative enhancers based upon the bidirectional transcription of enhancerassociated enhancer RNA (eRNA) (Andersson et al., 2014) . The kinetics of GR binding and loading of chromatin remodeling complexes in cell lines indicate that conformational changes induced by GC may be rapid-within minutes Nagaich et al., 2004; Voss et al., 2011) . To examine these kinetics in macrophages, we measured GR binding at the Fkbp5 locus over a 1-hr time course. There was evidence of GR binding at either enhancer within 5 min of Dex addition. Maximal binding at the À28-kb element occurred by 15 min (Figures 1C and S1B) , while binding at +65 kb had slower kinetics, being detectable by 15 min and increasing 1 hr after Dex addition.
GR Binding Is Associated with Rapid and Persistent Chromatin Decompaction at Fkbp5
To better understand the relationship between GR binding and long-range chromatin structure, we analyzed chromatin compaction by 3D DNA-FISH (Eskeland et al., 2010; Williamson et al., 2014) using one probe overlapping the À28-kb enhancer and extending to the Fkbp5 promoter, and another lying just beyond the +65-kb enhancer ( Figure 1B ). Following Dex treatment of mBMDMs, there was a rapid (<5-min) increase in the average inter-probe distances measured across the Fkbp5 locus ( Figures 1D and 1E ). We will refer to this phenomenon as locus decompaction. Figure S2 shows further illustrative images, with and without Dex treatment, from each of the loci tested here. Chromatin decompaction across the Fkbp5 locus preceded detectable increased stable Fkbp5 mRNA production ( Figure 1A ) and was maintained even after 24 hr ( Figure 1E ). To determine whether chromatin decompaction persists beyond the initial exposure period, Dex was washed out from the culture medium. Fkbp5 mRNA levels returned to near baseline within 24 hr of washout ( Figure 1A ). However, chromatin decompaction persisted for 5 days after ligand washout ( Figure 1F ). Surprisingly, ChIP showed that GR binding at the +65-kb enhancer is transient, decaying completely after 24 hr, regardless of whether Dex was washed out after 1 hr ( Figures 1G and S1C ). These data suggest that GR binding has a direct and long-lasting effect on large-scale chromatin structure at the Fkbp5 locus that occurs before the appearance of Fkbp5 mRNA and persists after Fkbp5 mRNA is no longer produced, and after GR binding is lost. 
Chromatin Decompaction Is Slow and Transient at a GC-Responsive Locus Where GR Is Not Bound
Most, but not all, GC-inducible genes in mBMDMs have detectable GR bound in their vicinity (±1,000 kb) (Jubb et al., 2016) . For responsive genes without detectable GR binding in the general vicinity, transcriptional activation is likely to be a secondary consequence of GC induction of TFs. Eight of the GC-inducible genes in macrophages encode TFs, including four (Fos, Hivep2, Klf4, and NcoA5) that were induced within 2 hr and might contribute to downstream target gene induction. The Tmod1 locus, which shares the same kinetics of gene activation in response to Dex as Fkbp5 (Figure 2A ), did not show evidence of regulated GR binding anywhere within its immediate vicinity ( Figure 2B ), or indeed anywhere within the wider Mb domain that likely encompasses an entire topologically associated domain ( Figure S3 ) (Dixon et al., 2012) . By contrast to the rapid and sustained effect at Fkbp5, FISH indicated that chromatin decompaction across the Tmod1 locus in response to GC occurred more slowly (1-4 hr), paralleled the kinetics of mRNA induction, and was not sustained at 24 hr ( Figures 2C  and 2D ).
Rapid Chromatin Decompaction Occurs at Multiple Loci
Fkbp5 has a specific role in feedback control of the response to GCs, and so could have a unique mode of regulation. We therefore analyzed several other GR-bound loci that differ in whether the response to GC was conserved across species. One of these is a large (720-kb) cluster of genes for the tetraspanin family of transmembrane proteins (referred to here as Ms4xxx). A peak of Dex-induced GR binding is located in the center of the Ms4xxx cluster, between Ms4a7 and Ms4a4c ( Figure 3B ). Interestingly, Ms4a4c and Ms4a4b, close to the GR binding site, are not induced by GC, but the more distant Ms4a6b, Ms4a6c, and Ms4a6d were significantly induced by Dex, albeit more slowly than for Fkbp5 ( Figure 3A ). Ms4a family members were also induced in human macrophages, also associated with GR binding to the locus (Jubb et al., 2016) . Despite the slower kinetics of gene induction, FISH revealed that, as seen at Fkbp5, there was rapid (within 5 min) and sustained chromatin decompaction across the central part of the Ms4xxx locus after Dex treatment ( Figures 3C and 3D and S2) .
A third example of a conserved GR-inducible locus was Klhl6/ B3gnt5/Klhl24 (Figure S4A) , where all three transcripts were induced by Dex. Here again, we observed rapid locus decompaction upon addition of Dex that was sustained for at least 24 hr ( Figures 4A and 4B , images from further time points are shown in Figure S2) .
We speculated that genes induced by GC only in one species (mouse or human), but not both, might exhibit distinct modes of induction. Accordingly, we examined two lociTns1, which had a local GR peak, and Dst, which did notinduced by Dex in mBMDMs but not in human monocytederived macrophages ( Figures S4B and S4C ). Dex induced rapid chromatin decompaction at these two loci, but by contrast with loci with conserved GC responses between species, this was not sustained beyond the first 5 min ( Figures 4C  and 4D) .
As observed at the Fkbp5 (+65) enhancer, the sustained chromatin decompaction observed at the Ms4xxx locus was not associated with continuous GR binding. GR binding was undetectable at both the Ms4xxx and Tns1 loci after 24 hr, regardless of whether or not the agonist was washed out after 1 hr ( Figures  4E and S5 ).
Rapid Chromatin Decompaction at GR-Bound Loci Can Occur without Transcription
Chromatin at actively transcribed regions is generally less compact than at silenced regions (Chambeyron and Bickmore 2004; Naughton et al., 2013) . Therefore, the decompaction we observed in response to Dex could be a consequence of, rather than causally linked to, transcriptional activation induced by GR. The rapidity of the response (within 5 min) and the persistence long after loss of GR binding ( Figure 4E ) and target gene inactivation, argue against the simple proposition that chromatin decompaction is associated with the act of transcription. However, to test this directly, we used a-amanitin to inhibit transcription by RNA Polymerase II. At Tmod1, where the induction by Dex is presumed to be indirect given the lack of GR binding ( Figures 2B and  S3 ), pre-treatment of mBMDM with a-amanitin for 4 hr ablated the Dex-dependent changes in chromatin compaction (Figures 5A and 5B). Unexpectedly, a-amanitin also prevented detectable chromatin changes at Klhl6/B3gnt5 ( Figure 5C ). This suggests either that this response is associated with transcription directly, or that it depends upon a labile regulator that decays, or is not Figure S5 ).
produced, in the presence of the inhibitor (Stacey et al., 1994) . Although the GR-bound enhancer at the Klhl6/B3gnt5 locus has conserved GR and PU.1 consensus motifs, its GR-ChIP-seq peak is weaker than those at the Fkbp5 and Ms4xxx loci. By contrast, Dex still induced significant chromatin decompaction at the Fkbp5 (Figures 5D and 5F ) and the Ms4xxx loci ( Figure 5E ) in the presence of a-amanitin, albeit with slightly delayed kinetics.
DISCUSSION
Single-cell imaging indicates that the binding of the GR, and associated coactivators that recruit chromatin remodeling complexes (GRIP1, BRG1), is dynamic and rapidly reversible (Paakinaho et al., 2017) . In the present study, we have shown that GC produces very rapid changes to higher-order (Figure 2A ) in nuclei from mBMDM that have been pretreated with 2.5 mg/mL a-amanitin for 4 hr, and then treated with 100 nM Dex for the indicated time. Scale bar represents 1 mm. (B) Inter-probe distances measured across Tmod1 locus after pretreatment with a-amanitin for 4 hr and then treatment with 100 nM Dex for the indicated times. n = 120 for each dataset. *p < 0.05, Wilcoxon rank sum. (C-E) Analogous to (B) but measured across the (C) Klhl6/B3gnt5, (D) Fkbp5, and (E) Ms4xxx loci. (F) 3D DNA FISH images using probes across the Fkbp5 locus ( Figure 1B) showing nuclei from mBMDMs that have been pretreated with 2.5 mg/mL a-amanitin for 4 hr, and then treated with 100 nM Dex for the indicated time. Scale bar represents 1 mm.
chromatin structure in macrophages at genomic sites where GR binds directly to DNA. Moreover, these changes persist for prolonged periods beyond the exposure to GC and do not depend upon the continuous presence of bound GR. It has been suggested that GR occupancy patterns in different cell types are predetermined by the distinctive baseline nucleosome accessibility patterns, a significant minority of which are then altered after GC treatment . Local transient GR binding can promote subsequent binding of a variant GR to the same motif, a phenomenon referred to as ''assisted loading'' .
Sustained chromatin reorganization in response to GR is not universal among target loci. The three genes tested that were induced only in mice, Tns1, Tmod1, and Dst, showed decompaction in response to Dex, but this was not sustained ( Figures  4C and 4D) , even though one of these (Tns1) has a GR-bound enhancer. The observation that most, but not all, inducible DNase I hypersensitive sites (DHSs) revert to the pre-stimulation state following GR stimulation (Stavreva et al., 2015) suggests that these genes are in the majority.
The rapid chromatin decompaction we report at multiple GR-responsive loci is distinct from previous reports. Transient chromatin reorganization of the MMTV array detected following GC exposure could be prevented by blocking transcription (M€ uller et al., 2001 ). However, lack of effect of a-amanitin at one-half of the loci we studied ( Figure 5 ) suggests that transcription, per se, is not absolutely required for GR-induced decompaction.
At first sight, GR-induced chromatin decompaction at the Fkbp5 locus conflicts with evidence of the formation of a compact loop domain in GC-responsive loci inferred in other systems (Paakinaho et al., 2010; Klengel et al., 2013) . However, chromosome conformation capture and FISH assays can give apparently discordant views of spatial genome organization (Fraser et al., 2015; Williamson et al., 2014) and chromatin decompaction could still be permissive for transient, rather than stable, interactions between elements that can be captured by 3C methods. We cannot exclude that the decompaction we observe represents GC-induced dissolution of preformed chromatin loops. The action of the GR that we report here is reminiscent of large-scale chromatin decompaction induced by other nuclear hormone receptors: the ecdysone receptor, which induces visible chromatin decompaction (puffing) on Drosophila polytene chromosomes (Tulin and Spradling, 2003; Sawatsubashi et al., 2004) , and the estrogen receptor (Nye et al., 2002; Rafique et al., 2015) . The molecular details of these decompact chromatin structures are yet to be elucidated.
The loss of bound GR from target loci, despite the continued presence of the agonist, is reminiscent of the state of tolerance elicited in macrophages by lipopolysaccharide (Seeley and Ghosh 2017) . Most explanations for GC resistance in human patients are based upon the regulation of cellular responsiveness by extrinsic signals, such as inflammatory cytokines and bacterial products (Bekhbat et al., 2017; Dendoncker and Libert 2017; Silverman et al., 2013; Silverman and Sternberg 2012) . Consistent with that view, the response of the mouse BMDMs studied herein, and by others (Oh et al., 2017) , is acutely regulated by CSF-1 (Hume and Gordon 1984) . Persistent changes in chromatin structure, and a failure to rapidly return to the chromatin ground state that existed before GC exposure, suggest an additional mechanism that may contribute. Chromatin reorganization at key target loci in response to GR binding could alter the likelihood of those loci being regulated by a future stimulus. However, the effects of GC are often context specific (Klengel et al., 2013) and primary macrophages in culture evolve over time. It remains to be seen whether sustained chromatin decompaction can be observed in monocyte/macrophages derived from GC-treated patients and whether this is associated with either therapeutic efficacy, or the development of GC resistance. 
Cell Culture
The 8-to 10-week male wild-type C57BL/6 mice were culled by cervical dislocation. Bone marrow was flushed from hindlimbs and then cultured in RPMI supplemented with penicillin/streptomycin, Glutamax (Invitrogen), and 10% fetal calf serum for 7 days in the presence of 10 4 U/mL rhCSF-1. The resulting mBMDMs were replated onto Superfrost microscope slides (Thermo) at 5 3 10 5 cells/mL and treated as indicated with 100 nM Dex (Sigma) or ethanol vehicle. Where described, cells were pre-treated with 2.5 mg/mL a-amanitin (Sigma) for 4 hr. Dex was washed out by removal of ligand-containing medium, washing gently once with fresh medium and then returning to culture in further fresh medium.
Chromatin Immunoprecipitation
Antibodies used for chromatin immunoprecipitation of mouse GR were BuGR2 (1 mg/10 6 cells; Thermo Fisher/Pierce) and rabbit IgG sc-2025 (Santa Cruz).
To prepare antibody-bound beads, 20 mL of Protein A Dynabeads (Invitrogen) per immunoprecipitation (IP) were washed once, and then diluted to 200 mL in block solution (13 PBS, 0.5% BSA, +2 mL of 0.1 M PMSF). Antibody was added and rotated for 3 hr at 4 C. Tris-HCl, pH 8.1, supplemented with protease inhibitors (Calbiochem), 1 mM DTT, and 0.2 mM PMSF (Sigma). The solution was diluted in IP dilution buffer (0.1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-HCl, pH 8.1) and sonicated using a Soniprep 150 to produce 300-to 500-bp average fragment sizes. Chromatin was spun for 10 min at 10,000 3 g (4 C), and then supplemented with 20% Triton X-100 to 1%, and BSA (Sigma) to 50 mg/mL. Input aliquots were removed and stored at À20 C. Chromatin was then added to the antibody-bound Protein A Dynabeads (Life Technologies) and rotated overnight at 4 C. After binding, beads were washed 3 3 10 min each in the following: (1) 1% IP dilution buffer; (2) 1% Triton X-100/0.1% Na-deoxycholate/0.1% SDS, 50 mM HEPES, pH 7.9, 500 mM NaCl, 1 mM EDTA; and (3) 0.5% Na-deoxycholate/0.5% NP-40, 20 mM Tris-HCl, pH 8, 1 mM EDTA, and 250 mM LiCl. Chromatin was extracted at 37 C for 15 min on a vibrating platform in 100 mL of extraction buffer (0.1 M NaHCO 3 , 1% SDS). To reverse cross-links, samples were supplemented to 300 mM with NaCl, treated with RNaseA (20 mg) (Roche), and then incubated for $8 hr at 65 C.
Proteinase K (40 mg) (Genaxxon) was added, and samples were incubated at 55 C for 1 hr. DNA was purified using the QIAquick PCR purification kit (QIAGEN). Real-time qPCR analysis to determine percent input bound at known GR target loci was carried out on a LightCycler 480 System using SYBR Green Master Mix (Roche).
Primers
Primers are listed in Table 1 .
3D DNA FISH
Paraformaldehyde (pFA)-fixed cells were permeabilized in 0.5% Triton X-100, washed in PBS, and stored at À80 C. 3D-FISH was carried out as previously described (Eskeland et al., 2010) . Slides were imaged and analyzed as described previously (Williamson et al., 2012) . The statistical significance of differences in n (values in figure legends) measured inter-probe distances was assessed using the nonparametric Wilcoxon rank sum test in R. Fosmid clones were from BACPAC Resource Center (Oakland, CA) and are listed in Table 2 .
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